Clover Health Investments Financial Ratios
NASDAQ: CLOVHealth CareMedical SpecialitiesUSD
4.79+0.21 (+4.59%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Clover Health Investments ratio analysis
Clover Health Investments earned a net margin of -4.4% in FY 2025, down from -3.1% a year earlier. Return on equity reached -27.7%, meaning Clover Health Investments generated -0.28 dollars of profit for every dollar of shareholders' equity. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Clover Health Investments financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Price / sales | 0.64 | 1.18 | 0.36 | 0.40 | 1.04 | 2.21 | — |
| Price / book | 4.00 | 4.73 | 1.60 | 1.24 | 2.87 | — | — |
| Gross margin | — | — | 20.4% | 6.4% | -5.4% | — | — |
| Operating margin | -4.4% | -3.3% | -16.3% | -26.1% | -43.3% | -13.8% | -39.6% |
| Net margin | -4.4% | -3.1% | -16.9% | -31.0% | -39.9% | -20.3% | -78.7% |
| Free cash flow margin | -3.6% | 2.4% | -11.5% | -19.0% | -19.2% | -17.7% | -34.6% |
| Return on equity (ROE) | -27.7% | -12.6% | -74.5% | -95.1% | -109.8% | — | — |
| Return on assets (ROA) | -15.8% | -7.4% | -37.4% | -42.0% | -61.8% | -51.0% | -362,482.8% |
| Debt / equity | — | — | — | 0.00 | 0.04 | — | — |
| Current ratio | 1.47 | 1.61 | 1.64 | 1.45 | 2.02 | 1.16 | 0.00 |
| Revenue growth | 40.3% | 8.8% | 15.0% | -25.5% | 118.8% | 45.6% | — |